Quintrio
Home

SERVICES-HEALTH SERVICES

P3 Health Partners Inc. Common Stock

PIII

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

Last trade $2.18
Day change -$0.235 (-9.75%)
Day range $2.17 – $2.41
Volume 15,410
Market cap $10M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$9.68M
Price / earnings
—
Price / book
0.09×
Price / sales
0.01×
EV / sales
0.06×
EV / EBITDA
32.13×

Profitability

Earnings per share
-$18.92
Return on assets
-11.34%
Return on equity
-70.82%
Dividend yield
0%

Liquidity and leverage

Debt / equity
1.14×
Current ratio
0.53×
Quick ratio
0.53×
Cash ratio
0.11×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$115.99M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for PIII, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$396.34M$386.38M$386.39M$384.81M$345.25M$355.79M$373.23M$370.69M
Cost of revenue$346M$300.38M$336.02M$426.06M$369.79M$351.35M$372.04M$410.22M
Gross profit$50.34M$86M$50.37M-$41.24M-$24.54M$4.44M$1.18M-$39.54M
Selling, general and administrative$34.28M$32.39M$25.77M$36.21M$22.39M$23.45M$25.18M$31.83M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$27.36M$44.78M$42.13M$112.62M$19.69M$38.56M$39.27M$98.97M
Operating income$22.98M$41.23M$8.24M-$153.87M-$44.22M-$34.12M-$38.09M-$138.5M
Interest expense-$5.04M-$7.86M$0-$15.64M-$20.53M-$10.15M$0-$6.83M
Income before taxes$30.8M$16.92M-$7.96M-$166.75M-$69.45M-$41.68M-$43.17M-$124.2M
Income taxes$23K$1.27M-$11M-$1.04M$11K$1.98M$1.07M$4.95M
Net income$30.78M$15.65M$3.04M-$165.71M-$69.46M-$43.67M-$44.25M-$129.15M
Net income attributable to common shareholders$451K-$2.13M$1.22M-$75.52M-$31.59M-$20.36M-$20.48M-$58.62M
EBITDA$44.02M$62.27M$29.31M-$132.87M-$23.19M-$13.04M-$17.04M-$109.29M
Basic earnings per share$0.13-$0.63$0.37-$23.02-$9.67-$6.23-$6.28-$17.94
Diluted earnings per share$0.07-$0.63$0.32-$23.02-$9.67-$6.23-$6.28-$17.95

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims against P3 Health Partners, Inc. (PIII) for allegedly making false and misleading statements or omissions in violation of federal securities laws. The investigation is triggered by P3's disappointing financial results and a civil investigative demand from the Department of Justice.

Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance. Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year. Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Gaxos.ai Inc. (NASDAQ: GXAI) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself. Veritone, Inc. (NASDAQ: VERI) gained 52.4% to $2.6076 following strong sales results. NuCana plc (NASDAQ: NCNA) gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance." The Beauty Health Company (NASDAQ: SKIN) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results. Arq, Inc. (NASDAQ: ARQ) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results. MicroCloud Hologram Inc. (NASDAQ: HOLO) jumped 26.6% to $6.19. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 26.2% to $0.1055. Nature's Sunshine Products, Inc. (NASDAQ: NATR) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance. Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5. Li-Cycle Holdings Corp. (NASDAQ: LICY) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 14, 20251-for-50reverse split